Cell Systems - Attachment Factor™
Attachment Factor™ promotes cell attachment to tissue culture surfaces
Attachment Factor™ (4Z0-210) is an extracellular matrix (ECM) product that promotes cell attachment to tissue culture surfaces and encourages correct polarity and cytoskeletal organization. Attachment Factor™ also contributes to correct in vitro growth factor and biological response modifier presentation. Use of Attachment Factor™ is critically important when cultures are to be initiated, grown, passaged, or used within the Cell Systems Media family. CSC media and reagents are Sterile, made with WFI and all components are cGMP and ISO Compliant.
The biologically active elements of Attachment Factor™ are derived by a chromatographic process from heat-inactivated charcoal-stripped fetal bovine serum, and delivered at 1X in a PBS based HEPES-buffered collagen vehicle. Cell Systems exclusively uses and strongly recommends the use of serum products 100% traceable to cattle processed in the US at USDA inspected facilities.
Use of Attachment Factor™ improves plating efficiency, shortens "lag time" after passage, enhances growth rates, and promotes the organization of polarity and cytoskeletal architecture, and can dramatically increase cell yield during cell culture expansion. Use with all cultures EXCEPT Melanocyte and Keratinocyte cells.
Handling and Storage
Store Attachment Factor™ <20°C. Once product is opened, shelf life is 30 days at refrigerated temperatures (4 - 8°C). Warm to 37°C in water bath before each use. Refrigerate immediately after use.
For use of Attachment Factor™ in passaging and plating of cells, please see our FAQ section.
- "Different Regulation of p53 Expression by Cadmium Exposure in Kidney, Liver, Intestine, Vasculature, and Brain Astrocytes" (Jin-Yong Lee, 2016)
- "Optimization of an in vitro human blood–brain barrier model: Application to blood monocyte transmigration assays" (Alexandre Paradis, 2015)
- "A2A adenosine receptor regulates the human blood brain barrier permeability" (Do-Geun Kim, 2014)
- "Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells" (Sher Zaman Safi, 2014)
- "Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential" (Ravinder Kodela, 2013)
- "Rk1, a Ginsenoside, Is a New Blocker of Vascular Leakage Acting through Actin Structure Remodeling"(Yong-Sun Maeng, 2013)
- High-Glucose-Induced Endothelial Cell Injury Is Inhibited by a Peptide Derived from Human Apolipoprotein E (Partha S. Bhattacharjee, 2012)